Showing results (161-170 of 297) with videos related to

Sort By:
Pageof 30
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2017
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinomaCristian Turato, Anna Balasso, Vinicio Carloni, et al.
Oncotarget|March 24, 2018
Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinomaRusdina Bte Ladju, Devis Pascut, Muhammad Nasrum Massi, et al.
BMC Gastroenterology|November 4, 2006
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general populationGiorgio Bedogni, Stefano Bellentani, Lucia Miglioli, et al.
Oncotarget|February 9, 2018
Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinomaRusdina Bte Ladju, Devis Pascut, Muhammad Nasrum Massi, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective studyFabio Piscaglia, Gianluca Svegliati-Baroni, Andrea Barchetti, et al.
Scientific Reports|June 6, 2019
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patientsDevis Pascut, Helena Krmac, Francesca Gilardi, et al.
Frontiers in Endocrinology|July 9, 2026
Innovative models to explore hepatic involvement in Prader-Willi syndromeRomar Guintu Dabban, Graziano Grugni, Adele Bondesan, et al.
Hepatology (Baltimore, Md.)|August 10, 2007
Incidence and natural course of fatty liver in the general population: the Dionysos studyGiorgio Bedogni, Lucia Miglioli, Flora Masutti, et al.
International Journal of Molecular Sciences|May 9, 2019
Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia NigraMatteo Dal Ben, Rosario Bongiovanni, Simone Tuniz, et al.
Pageof 30